Insurance and regulatory

Formulary tier

Coverage barriers, FDA enforcement, and the off-label vs on-label distinction.

Definition

The cost-share level a prescription drug occupies in an insurance plan's formulary (covered drug list). Tier 1 = generic ($), Tier 2 = preferred brand ($$), Tier 3 = non-preferred brand ($$$), Tier 4 = specialty (highest copay). Wegovy and Zepbound are typically Tier 3 or 4 on commercial plans — meaning copays of $100-$500+/month even after approval. Some plans exclude them entirely. Generic GLP-1s do not yet exist (semaglutide patent runs through 2032 in the US).

Insurance coverage Q&A hub →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Formulary tier in plain English

A formulary is the list of prescription drugs a health plan agrees to cover. HealthCare.gov defines it simply as that list, and notes it may also be called a preferred drug list. What the definition does not convey is that the list is layered — drugs are sorted into tiers, and the tier determines what you pay.

The structure is broadly consistent across commercial plans: the lowest tier holds generics and costs the least, middle tiers hold preferred and then non-preferred brand-name drugs, and the highest tier is reserved for specialty medications, where the patient share is often a percentage of the price rather than a flat copay. A drug can also be excluded from the formulary entirely, which is not the same as being denied — it means the plan does not cover it at any tier.

GLP-1 weight-management drugs sit near the top of that structure when they are covered at all, because there is no generic alternative to place them against. Tier placement is not decided by your doctor or even, usually, by your insurer directly. It is negotiated by a pharmacy benefit manager, and the FTC has documented how concentrated that market is: the top three PBMs processed nearly 80% of the roughly 6.6 billion prescriptions dispensed in the United States in 2023.

The common confusion is assuming approval settles the cost question. Prior authorization decides whether the plan pays; the tier decides how much you pay. People routinely win an appeal and then discover their share is still hundreds of dollars a month because the drug landed on a specialty tier with coinsurance rather than a copay.

Worth asking: which tier your specific drug sits on for your specific plan year, whether a lower-tier alternative exists that your clinician considers reasonable, and whether a tier exception can be requested with a medical justification. Our employer coverage checker and savings calculator help you model the real number, and the insurance questions hub covers appeals.

Related terms in Insurance and regulatory

Looking for more depth?

Sources

  1. Formulary — HealthCare.gov Glossary, Centers for Medicare & Medicaid Services
  2. FTC Releases Interim Staff Report on Prescription Drug Middlemen (July 2024) — U.S. Federal Trade Commission